Lepu Biopharma Co Ltd (hkse:02157) Share Price

Company Profile

Business description
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in Mainland China. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain. The company generates the majority of its revenue from the Sale of pharmaceutical products. The company also generates a small portion of its revenue from Licensing income.
Contact
No. 651, Lianheng Road
Minhang District
Shanghai201112
CHN
T: +86 2167680899
https://www.lepubiopharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
546

Recommended

SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.

Franco Granda | 11 March 2026

Fiercer competition expected to squeeze margins.

Shane Ponraj, CFA | 11 March 2026

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.

Shaun Ler | 10 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,976.80	44.30	0.50%
CAC 40	8,041.81	126.45	1.60%
DAX 40	23,640.03	328.60	-1.37%
Dow JONES (US)	47,417.27	289.24	-0.61%
FTSE 100	10,353.77	58.47	-0.56%
HKSE	25,898.76	490.30	1.93%
NASDAQ	22,716.13	19.03	0.08%
Nikkei 225	55,025.37	776.98	1.43%
NZX 50 Index	13,293.13	194.30	1.48%
S&P 500	6,775.80	5.68	-0.08%
S&P/ASX 200	8,743.50	39.10	0.45%
SSE Composite Index	4,133.43	10.29	0.25%